D.E. Shaw & Co’s Longboard Pharmaceuticals, Inc. Common Stock LBPH Stock Holding History

D.E. Shaw & Co’s Portfolio LBPH Stock Details LBPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-6,800	Closed	-$227K	–	5069
2024 Q3	$227K	Buy	+6,800	New	+$234K	﹤0.01%	4102

D.E. Shaw & Co's LBPH Position: Q4 2024 in Review

D.E. Shaw & Co sold out of Longboard Pharmaceuticals, Inc. Common Stock (LBPH) in Q4 2024, closing a stake of 6,800 shares — an estimated $227K sold.

D.E. Shaw & Co first reported a position in LBPH in Q3 2024 and held it in 1 quarter. The position peaked at $227K in Q3 2024. 0 funds tracked by Wall St. Rank hold LBPH as of Q4 2024.

D.E. Shaw & Co reported no remaining Longboard Pharmaceuticals, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
D.E. Shaw & Co sold 6,800 Longboard Pharmaceuticals, Inc. Common Stock shares in Q4 2024, an estimated $227K.
D.E. Shaw & Co first reported a position in Longboard Pharmaceuticals, Inc. Common Stock in Q3 2024 and held it in 1 quarter.
D.E. Shaw & Co's Longboard Pharmaceuticals, Inc. Common Stock position peaked at $227K in Q3 2024.
0 funds tracked by Wall St. Rank held Longboard Pharmaceuticals, Inc. Common Stock as of Q4 2024.

Based on D.E. Shaw & Co's 13F filing for Q4 2024, filed 14 Feb 2025.